European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

Kidney cancer: Every minute counts

Fri, 11 Nov 2011

European Multidisciplinary Meeting on Urological Cancers (EMUC) raised a vast array of controversial issues in onco-urology and offered essential updates, providing common ground for building bridges across disciplines.Organised by the European Association of Urology (EAU), the European Society for Medical Oncologists (ESMO) and the European Society for Radiotherapy and Oncology (ESTRO), the meeting took place on 4-6 November in Barcelona, Spain. More than 900 delegates, exhibitors and faculty joined the event, which proved to be highly interactive and stimulating.

The session dedicated to kidney cancer included two debates and a state-of-the art lecture on systemic treatment in metastatic disease, presented by Prof. C. Sternberg (IT). Prof. W. Artibani (IT), who formulated take-home messages in urology during the closing session of the 3rd EMUC, summarised some of the main insights in the field of RCC management.

”One clear message that we got from the session is that partial nephrectomy is now considered standard for T1a and T1b tumours,” he said. “This procedure can even be performed in selected cases on masses larger than 7cm in diameter.”

“Furthermore, it is vital to remember that every minute of warm ischemia time counts, for it determines the remaining function of the kidney,” he added.

Prof. Artibani strongly emphasised that the expertise of the surgeon remains to be the most important factor, as each technique has advantages and drawbacks. He pointed out that incision complications remain to be a challenge in the open nephrectomy, and touched upon the learning curve issues in the context of laparoscopic and robot assisted approaches. Intraoperative ultrasound and intraoperative fluorescence were also covered during the session.

The role of surgery in the management of metastatic disease is also gaining prominence, according to Artibani, who gave cytoreductive nephrectomy as an example.

“There are some uncertainties regarding the use of neoadjuvant targeted therapy, although we know for sure that biopsy of the tumour is always advised before TKI treatment.” said Artibani, referring to the arguments that had been presented by Prof. P. Mulders (NL) in his debate presentation.

Visit the official EMUC website

Share this article

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer